The Orthobiologics Market is predicted to reach US$ 9.66 billion by 2031 from US$ 5.44 billion in 2020, and to grow at a CAGR of ~5.4% between the forecast period 2021 to 2031.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2021 to 2031. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2020. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Products (Viscosupplementation Products, Synthetic Bone Substitutes, Demineralized Bone Matrices, Bone Morphogenic Protein, Allografts, and Stem Cells), Application (Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft-Tissue Injuries, and Maxillofacial & Dental Applications), End User (Hospitals & Orthopedic Clinics, Ambulatory Care Centers, Research & Academic Institutes, and Dental Clinics & Facilities)-
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Medtronic, DePuy Synthes, Stryker, Zimmer Biomet, Orthofix Medical Inc., Smith & Nephew, Bone Biologics Corp., Globus Medical, Bioventus, and RTI Surgical, among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Orthobiologics - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Orthobiologics - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Orthobiologics - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Orthobiologics - ANALYSIS & FORECAST, BY REGION
North America Orthobiologics
1. North America Orthobiologics , by Country
1. US
2. Canada
1. North America Orthobiologics , by Product
2. North America Orthobiologics , by Type
3. North America Orthobiologics , by Gender
4. North America Orthobiologics , by Sales Channel
3. Europe Orthobiologics
1. Europe Orthobiologics , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Orthobiologics , by Product
3. Europe Orthobiologics , by Type
4. Europe Orthobiologics , by Gender
5. Europe Orthobiologics , by Sales Channel
4. Asia Pacific Orthobiologics
1. Asia Pacific Orthobiologics , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Orthobiologics , by product
3. Asia Pacific Orthobiologics , by Type
4. Asia Pacific Orthobiologics , by Gender
5. Asia Pacific Orthobiologics , by Sales Channel
5. Rest of the World Orthobiologics
1. Rest of the World Orthobiologics , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Orthobiologics , by Product
3. Rest of the World Orthobiologics , by Type
4. Rest of the World Orthobiologics , by Gender
5. Rest of the World Orthobiologics , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 34